|
advertisement
|
|
|
| Journal Articles Details
|
|
More January, 2005 pharmacogenomics journal articles.- Pharmacogenetics: policy needs for personal prescribing.
by Melzer D, Raven A, Ling T, Detmer D, Zimmern R.
Journal: J Health Serv Res Policy. 10(1):40-4
- Oral cancer prevention and the evolution of molecular-targeted drug development.
by Lippman SM, Sudbø J, Hong WK.
Journal: J Clin Oncol. 23(2):346-56
- [Pharmacogenetics: Important aspects for dermatology.]
by Merk HF.
Journal: Hautarzt. :
- Population pharmacokinetics of CCI-779: correlations to safety and pharmacogenomic responses in patients with advanced renal cancer.
by Boni JP, Leister C, Bender G, Fitzpatrick V, Twine N, Stover J, Dorner A, Immermann F, Burczynski ME.
Journal: Clin Pharmacol Ther. 77(1):76-89
- Medicinal chemistry, metabolic profiling and drug target discovery: a role for metabolic profiling in reverse pharmacology and chemical genetics.
by Harrigan GG, Brackett DJ, Boros LG.
Journal: Mini Rev Med Chem. 5(1):13-20
- Clinical consequences of cytochrome P450 2C9 polymorphisms.
by Kirchheiner J, Brockmöller J.
Journal: Clin Pharmacol Ther. 77(1):1-16
- Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.
by Kwan P, Brodie MJ.
Journal: Epilepsia. 46(2):224-35
- Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: roles of intracellular calcium, GRP78 and Bcl-2.
by Hiroi T, Wei H, Hough C, Leeds P, Chuang DM.
Journal: Pharmacogenomics J. :
- Integrative epidemiology: from risk assessment to outcome prediction.
by Spitz MR, Wu X, Mills G.
Journal: J Clin Oncol. 23(2):267-75
- Correlating gene expression with chemical scaffolds of cytotoxic agents: ellipticines as substrates and inhibitors of MDR1.
by Huang Y, Blower PE, Yang C, Barbacioru C, Dai Z, Zhang Y, Xiao JJ, Chan KK, Sadée W.
Journal: Pharmacogenomics J. :
- Treating tobacco dependence: state of the science and new directions.
by Lerman C, Patterson F, Berrettini W.
Journal: J Clin Oncol. 23(2):311-23
- Drug evaluation, drug development and pharmacogenetics: celebrating 30 years of progress.
by Li Wan Po A.
Journal: J Clin Pharm Ther. 30(1):1-4
- Association between the DRD2 gene Taq1A (C32806T) polymorphism and alcohol consumption in social drinkers.
by Munafò MR, Johnstone EC, Welsh KI, Walton RT.
Journal: Pharmacogenomics J. :
- Utilization of Human Liver Microsomes to Explain Individual Differences in Paclitaxel Metabolism by CYP2C8 and CYP3A4.
by Taniguchi R, Kumai T, Matsumoto N, Watanabe M, Kamio K, Suzuki S, Kobayashi S.
Journal: J Pharmacol Sci. 97(1):83-90
- Cytogenetics and gene discovery in psychiatric disorders.
by Pickard BS, Millar JK, Porteous DJ, Muir WJ, Blackwood DH.
Journal: Pharmacogenomics J. :
- Live smallpox experiments may go ahead.
by Senior K.
Journal: Lancet Infect Dis. 5(1):10
- Use of proteasome inhibition in the treatment of lung cancer.
by Schenkein DP.
Journal: Clin Lung Cancer. 6 Suppl 2:S89-96
- Asthma Treatment in the 21st Century: What's Next?
by Peters SP.
Journal: Clin Rev Allergy Immunol. 27(3):197-206
- Advances in childhood leukaemia: successful clinical-trials research leads to individualised therapy.
by Ziegler DS, Dalla Pozza L, Waters KD, Marshall GM.
Journal: Med J Aust. 182(2):78-81
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|